Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00253682 · ClinicalTrials.gov registry record

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

A clinical trial of HIV Infections and Cardiovascular Diseases, sponsored by University of Miami.

Completed
Registry status
167
Enrollment target
5
Study locations

NCT00253682 is a study of HIV Infections and Cardiovascular Diseases that has completed, run by University of Miami. The registered enrollment target is 167 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00253682, a study of HIV Infections and Cardiovascular Diseases, has completed, sponsored by University of Miami.

COMPLETED
Registry status
167 participants
Enrollment target
5
Study locations

Study Summary

This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.

Study Locations (5)

Florida

  • University of Miami School of Medicine - Miami

Illinois

  • University of Illinois - Chicago - Chicago

Massachusetts

  • Boston Medical Center - Boston

New York

  • Columbia University - New York

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 167 participants
Start Date 2002-09
Est. Completion 2006-12

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT00253682

The ClinicalTrials.gov registry entry for NCT00253682 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00253682 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00253682 about?

NCT00253682 is a clinical study titled "Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers". This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.

What is the current status of trial NCT00253682?

This trial is currently completed. The enrollment target is 167 participants. The study started on 2002-09. Estimated completion is 2006-12.

What conditions does trial NCT00253682 study?

This clinical trial studies the following conditions: HIV Infections, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Cardiomyopathy, Hypertrophic.

Who is sponsoring clinical trial NCT00253682?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00253682 being conducted?

This trial has 5 study locations across Florida, Illinois, Massachusetts, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.